Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1995-06-07
2000-06-20
Feisee, Lila
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
435 697, 4353201, 435325, 530350, 5303873, C12N 1562, C12N 1552, C12N 1563, C12N 510
Patent
active
060779470
ABSTRACT:
The present invention is directed to novel chimeric proliferation receptor proteins and DNA sequences encoding these proteins where the chimeric proteins are characterized in three general categories. In one category, the novel chimeric proteins comprise at least three domains, namely, an extracellular inducer-responsive clustering domain capable of binding an extracellular inducer that transmits a signal to a proliferation signaling domain, a transmembrane domain and a proliferation signaling domain that signals a host cell to divide. In the second category, the novel chimeric proteins comprise at least two domains, namely, an intracellular inducer-responsive clustering domain capable of binding an intracellular inducer and a proliferation signaling domain that signals the cell to divide. In yet a third category, a novel hybrid chimeric protein receptor is contemplated that contains an intracellular or extracellular inducer domain, a transmembrane domain, a proliferation signaling domain and an effector signaling domain in a single chain molecule. Whether the binding domain is intracellular or extracellular, the binding of inducer to these novel chimeric receptor proteins induces the clustering of the binding domains to each other and further signals the cell to proliferate, and optionally, signal an effector function. The present invention further relates to expression vectors containing the nucleic acids encoding the novel chimeric receptors, cells expressing the novel chimeric receptors and therapeutic methods of using cells expressing these novel receptors for the treatment of cancer, infectious disease and autoimmune diseases, for example.
REFERENCES:
patent: 5359046 (1994-10-01), Capon et al.
patent: 5470730 (1995-11-01), Greenberg et al.
patent: 5504000 (1996-04-01), Littman et al.
Heinzel et al., Use of Simian Virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells, J. Virol. 62:3738-3746 (1988).
Kishimoto et al., Cytokine Signal Transduction, Cell 76:253-262 (1994).
Morgan and Anderson, Human Gene Therapy, Ann. Rev. Biochem. 62:191-217 (1993).
Mulligan, The Basic Science of Gene Therapy, Science 360:926-930 (1993).
Niehuis et al., Gene Transfer into Hematopoietic Stem Cells, Cancer 67:2700-2704 (1991).
Orkin et al., Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy (1995).
Paul, Tumor Immunology, Fundamental Immunol., Chap. 34, pp. 923-955 (1989).
Riddell et al., Genetically Modified T-Cell Clones as a Treatment for Human Viral Diseases, Soc. Biol. Therapy, (Meeting Abstract), p. 50 (1993).
Spencer et al., Controlling Signal Transduction with Synthetic Ligands, Science 262:1019-1024 (1993).
Stancovski et al., Targeting of T Lymphocytes to Neu/Her-2-expressing Cells using chimeric Single Chain Fv Receptors, J. Immunol. 151:6577-6582 (1993).
Travis, Making Molecular matches in the Cell, Science 262:989 (1993).
Weatherall, Scope and Limitations of Gene Therapy, British med. Bull. 51:1-11 (1995).
Mangelsdorf et al. (1995) Cell 83:835-839, 1995.
Watson et al. (1994) The G-Protein Linked Receptor FactsBook, Academic Press Limited, San Diego, CA, pp. X-XL, 3-6, 1994.
Barclay et al. (1993) The Leucocyte Antigen FactsBook, Academic Press Limited, San Diego, CA, pp. 2-7, 22-25, 1993,
Bowie et al. (1990) Science.
Nakamura et al. Nature 369 : 330-333 (1994).
Miyazaki et al. Science 266 : 1045-1047 (1994).
Sakai et al. J. Biol. Chem. 270:18420-18427.
Capon Daniel J.
Siekevitz Miriam
Smith Douglas H.
Tian Huan
Winslow Genine A.
Cell Genesys Inc.
Feisee Lila
Pak Michael
LandOfFree
DNA encoding an intracellular chimeric receptor comprising Janus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding an intracellular chimeric receptor comprising Janus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding an intracellular chimeric receptor comprising Janus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1854607